Cefonus-T 250mg/31.25mg Injection
Marketer
Cronus Biotech Ltd
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Cefonus-T 250mg/31.25mg Injection
The dual-action injection, Cefonus-T 250mg/31.25mg, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be overseen by a medical professional. Complete the prescribed treatment regimen; premature cessation may reduce its effectiveness. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects or allergic reactions (rash, pruritus, edema, dyspnea) immediately. Inform your physician of all current medications, including those for pre-existing conditions. Pregnant or lactating individuals should consult their doctor before use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occur. Sufficient rest, nutritious food, and hydration are crucial for optimal recovery. Your doctor might order tests to monitor the medication's impact.
Uses of Cefonus-T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Cefonus-T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Cefonus-T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Cefonus-T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Cefonus-T 250mg/31.25mg Injection works:
Ceftriaxone and Tazobactum, combined as Cefonus-T 250mg/31.25mg Injection, offer a targeted antibacterial approach. Ceftriaxone, a third-generation cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Tazobactum, a beta-lactamase inhibitor, counters bacterial defenses, thus bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Cefonus-T 250mg/31.25mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Cefonus-T 250mg/31.25mg is typically deemed safe for use in pregnancy. Preclinical trials using animals revealed minimal or no harmful effects on fetal development; yet, data from human trials remain scarce.
Breast feedingCAUTION
The administration of Cefonus-T 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Cefonus-T 250mg/31.25mg Injection can induce drowsiness, visual disturbances, and dizziness. Refrain from operating a vehicle if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cefonus-T 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable formulation of Cefonus-T (250mg/31.25mg) requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alterations for Cefonus-T (250mg/31.25mg) injection are not advised for patients experiencing mild or moderately compromised liver function.
What if you forget to take Cefonus-T 250mg/31.25mg Injection :
Omitting a scheduled dose of Cefonus-T 250mg/31.25mg Injection necessitates contacting your physician.
Facts to Know About Cefonus-T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently